Rationale, design, methods and baseline characteristics of the Asklepios Study

European Journal of Preventive Cardiology

Volumn 14, Issue 2, 2007, Pages 179-191

  Rietzschel, Ernst R ^a,b   de Buyzere, Marc L ^a   Bekaert, Sofie ^b   Segers, Patrick ^b   De Bacquer, Dirk ^b   Cooman, Luc ^c   Van Damme, Piet ^c   Cassiman, Peter ^c   Langlois, Michel ^d   Van Oostveldt, Patrick ^b   Verdonck, Pascal ^b   de Backer, Guy ^b   Gillebert, Thierry C ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c Association of Primary Care Physicians Asklepios VOF   (Belgium)

^d General Hospital St Jan   (Belgium)

Author keywords

arterial tonometry; atherosclerosis; cardiovascular diseases; echocardiography; haemodynamics; intima media thickness; telomere

Indexed keywords

ADULT; AGING; ARTERIAL PRESSURE; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; BELGIUM; BIOCHEMISTRY; BLOOD CHEMISTRY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CAROTID ARTERY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; INFLAMMATION; INTIMA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; RISK ASSESSMENT; THROMBOSIS;

ADULT; BELGIUM; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; GLUCOSE METABOLISM DISORDERS; HUMANS; LIFE STYLE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUESTIONNAIRES; RESEARCH DESIGN; RISK FACTORS; SEX FACTORS; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 34247470881     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328012c380     Document Type: Article

References (119)

1. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prevent Rehabil 2003; 10(Suppl 1):S1–S78.
2. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987–1003.
3. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. Circulation 2002; 106: 388–391.
4. Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 1998; 97: 1876–1887.
5. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855–2864.
6. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746–2753.
7. Assmann GF, Cullen PF, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310–315.
8. De Vries N, van Riel PLCM, van de Putte LBA. Research in complex diseases. Lancet 2002; 359: 1243–1245.
9. Sing CF, Stengard JH, Kardia SL. Genes, environment, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003; 23: 1190–1196.
10. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39: 10–15.
11. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434–2439.
12. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001; 21: 2046–2050.
13. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570–574.
14. Simons PC, Algra A, Bots ML, Grobbee DE, van der GY. Common carotid intima–media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation 1999; 100: 951–957.
15. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima–media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432–1437.
16. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14–22.
17. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.
18. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000; 102: 470–479.
19. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima–media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87–92.
20. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657–663.
21. Willum Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664–670.
22. Bots ML, Dijk JM, Oren A, Grobbee DE. Carotid intima–media thickness, arterial stiffness and risk of cardiovascular disease: current evidence. J Hypertens 2002; 20: 2317–2325.
23. Garcia-Cardena G, Comander J, Anderson KR, Blackman BR, Gimbrone MA Jr. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A 2001; 98: 4478–4485.
24. Garcia-Cardena G, Comander JI, Blackman BR, Anderson KR, Gimbrone MA. Mechanosensitive endothelial gene expression profiles: scripts for the role of hemodynamics in atherogenesis? Ann NY Acad Sci 2001; 947: 1–6.
25. Van Bortel LM, Struijker-Boudier HA, Safar ME. Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001; 38: 914–921.
26. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999; 100: 1387–1393.
27. Boutouyrie P, Bussy C, Hayoz D, Hengstler J, Dartois N, Laloux B, et al. Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment. Circulation 2000; 101: 2601–2606.
28. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735–738.
29. Chen CH, Nakayama M, Nevo E, Fetics BJ, Maughan WL, Kass DA. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J Am Coll Cardiol 1998; 32: 1221–1227.
30. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714–720.
31. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, et al. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol 2001; 38: 2028–2034.
32. Kass DA. Age-related changes in venticular-arterial coupling: pathophysiologic implications. Heart Fail Rev 2002; 7: 51–62.
33. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation 1992; 86: 513–521.
34. Nichols WW, O'Rourke MF, editors. Vascular impedance. In: McDonald's blood flow in arteries. London: Arnold; 1998. pp. 243–283.
35. Nichols WW, O'Rourke MF, editors. Pulsatile pressure-flow relations. In: McDonald's blood flow in arteries. London: Arnold; 1998. pp. 98–113.
36. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 2005; 289: H501–H512.
37. De Santis D, Abete P, Testa G, Cacciatore F, Galizia G, Leosco D, et al. Echocardiographic evaluation of left ventricular end-systolic elastance in the elderly. Eur J Heart Fail 2005; 7: 829–833.
38. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension 2005; 46: 185–193.
39. Redfield MM, Jacobsen SJ, Borlaug BA, Rodeheffer RJ, Kass DA. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005; 112: 2254–2262.
40. Westerhof N, Stergiopulos N, Noble N. Snapshots of hemodynamics. An aid for clinical research and graduate education. New York: Springer Science and Business Media; 2004.
41. Lakatta EG, Levy D. Arterial and cardiac ageing: major shareholders in cardiovascular disease enterprises: Part II: The ageing heart in health: links to heart disease. Circulation 2003; 107: 346–354.
42. Lakatta EG. Arterial and cardiac ageing: major shareholders in cardiovascular disease enterprises: Part III: Cellular and molecular clues to heart and arterial ageing. Circulation 2003; 107: 490–497.
43. Lakatta EG, Levy D. Arterial and cardiac ageing: major shareholders in cardiovascular disease enterprises: Part I: Ageing arteries: a ‘set up’ for vascular disease. Circulation 2003; 107: 139–146.
44. Bekaert S, De Meyer T, Van Oostveldt P. Telomere attrition as ageing biomarker. Anticancer Res 2005; 25: 3011–3021.
45. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585–621.
46. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992; 89: 10114–10118.
47. Chang E, Harley CB. Telomere length and replicative ageing in human vascular tissues. Proc Natl Acad Sci U S A 1995; 92: 11190–11194.
48. Frenck RW Jr, Blackburn EH, Shannon KM. The rate of telomere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A 1998; 95: 5607–5610.
49. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458–460.
50. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994; 91: 9857–9860.
51. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973; 41: 181–190.
52. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349–352.
53. Bird J, Ostler EL, Faragher RG. Can we say that senescent cells cause ageing? Exp Gerontol 2003; 38: 1319–1326.
54. Campisi J. From cells to organisms: can we learn about ageing from cells in culture? Exp Gerontol 2001; 36: 607–618.
55. Edo MD, Andres V. Ageing, telomeres, and atherosclerosis. Cardiovasc Res 2005; 66: 213–221.
56. Gardner JP, Li S, Srinivasan SR, Chen W, Kimura M, Lu X, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005; 111: 2171–2177.
57. Serrano AL, Andres V. Telomeres and cardiovascular disease: does size matter? Circ Res 2004; 94: 575–584.
58. Bekaert S, Van Pottelbergh I, De Meyer T, Zmierczak H, Kaufman JM, Van Oostveldt P, et al. Telomere length versus hormonal and bone mineral status in healthy elderly men. Mech Ageing Dev 2005; 126: 1115–1122.
59. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, et al. Estrogen activates telomerase. Cancer Res 1999; 59: 5917–5921.
60. Serra V, Grune T, Sitte N, Saretzki G, von Zglinicki T. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann NY Acad Sci 2000; 908: 327–330.
61. Graakjaer J, Bischoff C, Korsholm L, Holstebroe S, Vach W, Bohr VA, et al. The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech Ageing Dev 2003; 124: 629–640.
62. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004; 101: 17312–17315.
63. Londono-Vallejo JA, DerSarkissian H, Cazes L, Thomas G. Differences in telomere length between homologous chromosomes in humans. Nucl Acids Res 2001; 29: 3164–3171.
64. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet 1994; 55: 876–882.
65. Spyridopoulos I, Haendeler J, Urbich C, Brummendorf TH, Oh H, Schneider MD, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004; 110: 3136–3142.
66. Von Zglinicki T, Serra V, Lorenz M, Saretzki G, Lenzen-Grossimlighaus R, Gessner R, et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor? Lab Invest 2000; 80: 1739–1747.
67. Von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann NY Acad Sci 2000; 908: 99–110.
68. Von Zglinicki T, Martin-Ruiz CM. Telomeres as biomarkers for ageing and age-related diseases. Curr Mol Med 2005; 5: 197–203.
69. Xu D, Neville R, Finkel T. Homocysteine accelerates endothelial cell senescence. FEBS Lett 2000; 470: 20–24.
70. Aviv A, Valdes A, Gardner JP, Swaminathan R, Kimura M, Spector TD. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab 2006; 91: 635–640.
71. Aviv A. Hypothesis: pulse pressure and human longevity. Hypertension 2001; 37: 1060–1066.
72. Aviv A. Chronology versus biology: telomeres, essential hypertension, and vascular ageing. Hypertension 2002; 40: 229–232.
73. Aviv A, Shay J, Christensen K, Wright W. The longevity gender gap: are telomeres the explanation? Sci Ageing Knowl Environ 2005; 2005. p. 16.
74. Aviv H, Khan MY, Skurnick J, Okuda K, Kimura M, Gardner J, et al. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 2001; 159: 281–287.
75. Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, et al. Telomere length as an indicator of biological ageing: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001; 37: 381–385.
76. Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, Adamopoulos C, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004; 43: 182–185.
77. Brouilette S, Singh RK, Thompson JR, Goodall AH, Samani NJ. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 842–846.
78. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393–395.
79. Nakashima H, Ozono R, Suyama C, Sueda T, Kambe M, Oshima T. Telomere attrition in white blood cell correlating with cardiovascular damage. Hypertens Res 2004; 27: 319–325.
80. Okuda K, Khan MY, Skurnick J, Kimura M, Aviv H, Aviv A. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis 2000; 152: 391–398.
81. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH. Telomere shortening in atherosclerosis. Lancet 2001; 358: 472–473.
82. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662–664.
83. World Health Organization. MONICA manual. Geneva: World Health Organization; 1990.
84. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105–114.
85. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a users manual, 4th printing, revised. Boston, MA: Health Institute; 1994.
86. Rose GA, Blackburn H. Cardiovascular survey methods. Monogr Ser WHO 1968; 56: 1–188.
87. Pedersen SS, Denollet J. Type D personality, cardiac events, and impaired quality of life: a review. Eur J Cardiovasc Prev Rehabil 2003; 10: 241–248.
88. Karasek R, Baker D, Marxer F, Ahlbom A, Theorell T. Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men. Am J Public Health 1981; 71: 694–705.
89. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347: 417–421.
90. Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and type D personality. Psychosom Med 2005; 67: 89–97.
91. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161–186.
92. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire UD, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995–1003.
93. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham Study. Ann Intern Med 1970; 72: 813–822.
94. Okin PM, Roman MJ, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 1995; 25: 417–423.
95. De Backer G, De Bacquer D, Brohet C, De Ceukelier S, Franck A, Krzentowsky G, et al. Recommendations for the prevention of cardiovascular diseases in clinical practice. Belgian Working Group on Prevention of Cardiovascular Diseases [in French]. Rev Med Brux 2005; 26: 77–87.
96. Ilyin SE, Belkowski SM, Plata-Salaman CR. Biomarker discovery and validation: technologies and integrative approaches. Trends Biotechnol 2004; 22: 411–416.
97. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002; 105: 1541–1544.
98. De Keulenaer GW, Chappell DC, Ishizaka N, Nerem RM, Alexander RW, Griendling KK. Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase. Circ Res 1998; 82: 1094–1101.
99. Ziegler T, Bouzourene K, Harrison VJ, Brunner HR, Hayoz D. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18: 686–692.
100. Brooks AR, Lelkes PI, Rubanyi GM. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genom 2002; 9: 27–41.
101. Davies PF, Zilberberg J, Helmke BP. Spatial microstimuli in endothelial mechanosignaling. Circ Res 2003; 92: 359–370.
102. Davies PF, Shi C, De Paola N, Helmke BP, Polacek DC. Hemodynamics and the focal origin of atherosclerosis: a spatial approach to endothelial structure, gene expression, and function. Ann NY Acad Sci 2001; 947: 7–16.
103. Gnasso A, Irace C, Carallo C, De Franceschi MS, Motti C, Mattioli PL, et al. In vivo association between low wall shear stress and plaque in subjects with asymmetrical carotid atherosclerosis. Stroke 1997; 28: 993–998.
104. Kornet L, Lambregts J, Hoeks APG, Reneman RS. Differences in near-wall shear rate in the carotid artery within subjects are associated with different intima–media thicknesses. Arterioscler Thromb Vasc Biol 1998; 18: 1877–1884.
105. Kornet L, Hoeks APG, Lambregts J, Reneman RS. In the femoral artery bifurcation, differences in mean wall shear stress within subjects are associated with different intima-media thicknesses. Arterioscler Thromb Vasc Biol 1999; 19: 2933–2939.
106. Gnasso A, Carallo C, Irace C, Spagnuolo V, De Novara G, Mattioli PL, et al. Association between intima-media thickness and wall shear stress in common carotid arteries in healthy male subjects. Circulation 1996; 94: 3257–3262.
107. Vander Laan PA, Reardon CA, Getz GS. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 2004; 24: 12–22.
108. Irace C, Cortese C, Fiaschi E, Carallo C, Farinaro E, Gnasso A. Wall shear stress is associated with intima-media thickness and carotid atherosclerosis in subjects at low coronary heart disease risk. Stroke 2004; 35: 464–468.
109. Willeit J, Kiechl S, Oberhollenzer F, Rungger G, Egger G, Bonora E, et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. Arterioscler Thromb Vasc Biol 2000; 20: 529–537.
110. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arterioscler Thromb Vasc Biol 1985; 5: 293–302.
111. Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon RF, Glagov S. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 1983; 53: 502–514.
112. Granger C, Van Eyk J, Mockrin S, Anderson N. National Heart, Lung and Blood Institute Clinical Proteomics Working Group report. Circulation 2004; 109: 1697–1703.
113. Bailey WJ, Ulrich R. Molecular profiling approaches for identifying novel biomarkers. Expert Opin Drug Safety 2004; 3: 137–151.
114. Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, Holmes E. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 2003; 128: 32–36.
115. Griffin JL. Metabolic profiles to define the genome: can we hear the phenotypes? Philos Trans R Soc Lond B Biol Sci 2004; 359: 857–871.
116. Lindon JC, Holmes E, Nicholson JK. Metabonomics and its role in drug development and disease diagnosis. Expert Rev Mol Diagn 2004; 4: 189–199.
117. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004; 9: 1–31.
118. Lindon JC, Holmes E, Nicholson JK. Metabonomics: systems biology in pharmaceutical research and development. Curr Opin Mol Ther 2004; 6: 265–272.
119. Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, et al. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 2002; 22: 1175–1180